Related references
Note: Only part of the references are listed.The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis
Hui Li et al.
SCIENTIFIC REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance
Manzar Alam et al.
CLINICAL ORAL INVESTIGATIONS (2017)
Nutrition, inflammation and cancer
Laurence Zitvogel et al.
NATURE IMMUNOLOGY (2017)
Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling
Guang Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Inflammatory networks underlying colorectal cancer
Audrey Lasry et al.
NATURE IMMUNOLOGY (2016)
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
Simona Taverna et al.
ONCOTARGET (2016)
Prognostic significance of RelB overexpression in non-small cell lung cancer patients
Hualong Qin et al.
THORACIC CANCER (2016)
rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment
Annapina Russo et al.
SCIENTIFIC REPORTS (2016)
NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth
Xiaojun Zha et al.
CANCER LETTERS (2015)
Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome
Duygu Kankaya et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Comprehensive Evaluation of Nuclear Factor-κB Expression Patterns in Non-Small Cell Lung Cancer
Ioanna Giopanou et al.
PLOS ONE (2015)
Co-expression of β-arrestin1 and NF-D0B is associated with cancer progression and poor prognosis in lung adenocarcinoma
Jianyu Yu et al.
TUMOR BIOLOGY (2015)
Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer
Ping Gao et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2015)
A new scoring system for predicting survival in patients with non-small cell lung cancer
Steven E. Schild et al.
CANCER MEDICINE (2015)
Unvalidated antibodies and misleading results
David Rimm et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Sprouty1 induces a senescence-associated secretory phenotype by regulating NFjB activity: implications for tumorigenesis
A. Macia et al.
CELL DEATH AND DIFFERENTIATION (2014)
NF-κB protein expression associates with 18F-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism
Viswam S. Nair et al.
LUNG CANCER (2014)
Analytic Variability in Immunohistochemistry Biomarker Studies
Valsamo K. Anagnostou et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
S. Al-Saad et al.
BRITISH JOURNAL OF CANCER (2008)
Potential biomarkers involving IKK/RelA signal in early stage non-small cell lung cancer
Xianqing Jin et al.
CANCER SCIENCE (2008)
Current issues in ER and HER2 testing by IHC in breast cancer
Allen M. Gown
MODERN PATHOLOGY (2008)
Combined prognostic value of both RelA and IκB-α expression in human non-small cell lung cancer
Dianliang Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Expression of nuclear factor-κB and its clinical significance in nonsmall-cell lung cancer
Zhenfa Zhang et al.
ANNALS OF THORACIC SURGERY (2006)
Allergen activates peripheral blood eosinophil nuclear factor-κB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-α and interleukin-8
WR Coward et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Role of NF-κB in p53-mediated programmed cell death
KM Ryan et al.
NATURE (2000)
Share Paper
